COVID-19
Conditions
Interventions
Group 1 :Zijin Prescription
Sponsors
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Eligibility
Sex/Gender
All
Age
10 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Age and gender are not limited; 2. Meet the diagnostic criteria for new coronary pneumonia; 3. Voluntarily accept TCM syndrome differentiation treatment; 4. Informed consent to this research.
Exclusion criteria
Exclusion criteria: 1. Severe and critical patients with new coronary pneumonia; 2. Any other chronic respiratory disease, respiratory bacterial infection such as suppurative tonsillitis, acute tracheo-bronchitis, sinusitis, otitis media and other respiratory diseases that affect the assessment; 3. Accompanied by severe pulmonary interstitial disease, bronchiectasis, primary immunodeficiency disease, congenital respiratory malformation, congenital heart disease, abnormal lung development and other basic diseases; 4. Accompanied by severe liver disease [aspartate aminotransferase (AST), alanine aminotransferase (ALT) exceeds 5 times the upper limit of normal value], or has severe renal insufficiency or is receiving continuous kidney disease substitution therapy, hemodialysis, peritoneal dialysis patients; 5. There are malignant tumors with multiple metastases that cannot be resected, hematological diseases, dyscrasias, active bleeding, severe malnutrition, AIDS (HIV), or severe neurological or mental diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| COVID-19 nucleic acid; | — |
Countries
China
Contacts
Public ContactShengxi Meng
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Outcome results
None listed